Reblozyl
Active substance: luspatercept
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · LUSPATERCEPT 75 mg/1
United StatesActive
Marketing holder: Celgene Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LUSPATERCEPT · 75 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-8a61-75b5-8718-91a42763270f,01a1209b-57fe-721f-8ac1-101c246f28df;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59572-775
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 59572-775 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59572-775 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59572-775 · Verified 2026-10-09 · open in source